Different phenotypes with different endings—Telomere biology disorders and cancer predisposition with long telomeres
Sharon A. Savage,Alison A. Bertuch,Team Telomere and the Clinical Care Consortium for Telomere‐Associated Ailments (CCCTAA),Suneet Agarwal,Geraldine Aubert,Fabian Beier,Carmem Bonfim,Tracy M. Bryan,Rodrigo T. Calado,Vivian Y. Chang,Jane E. Churpek,Edward W. Cowen,Courtney D. DiNardo,Carlo Dufour,Christen L. Ebens,Lucy C. Fox,Neelam Giri,Nicholas J. Gloude,Frederick Goldman,Emma M. Groarke,Fernanda Gutierrez‐Rodrigues,F. Bradley Johnson,Christian P. Kratz,Abhishek Mangaonkar,Lisa J. McReynolds,Maria Molina‐Molina,Kasiani C. Myers,Taizo A. Nakano,Adam S. Nelson,Marena R. Niewisch,Benjamin A. Raby,Christopher R. Reilly,Akiko Shimamura,Orna Steinberg‐Shemer,Moon Ley Tung,Marcin W. Wlodarski,Joanne Yacobovich,Inderjeet Dokal,Dirk Hockemeyer,Hilary J. Longhurst,Katie A. Stevens,Hemanth Tummala,Tom J. Vulliamy
DOI: https://doi.org/10.1111/bjh.19851
2024-10-29
British Journal of Haematology
Abstract:Germline pathogenic variants in genes impacting telomere maintenance and function have varied impacts on telomere biology and cellular and clinical phenotypes as illustrated here. Summary Rare germline pathogenic variants (GPVs) in genes essential in telomere length maintenance and function have been implicated in two broad classes of human disease. The telomere biology disorders (TBDs) are a spectrum of life‐threatening conditions, including bone marrow failure, liver and lung disease, cancer and other complications caused by GPVs in telomere maintenance genes that result in short and/or dysfunctional telomeres and reduced cellular replicative capacity. In contrast, cancer predisposition with long telomeres (CPLT) is a disorder associated with elevated risk of a variety of cancers, primarily melanoma, thyroid cancer, sarcoma, glioma and lymphoproliferative neoplasms caused by GPVs in shelterin complex genes that lead to excessive telomere elongation and increased cellular replicative capacity. While telomeres are at the root of both disorders, the term TBD is used to convey the clinical phenotypes driven by critically short or otherwise dysfunctional telomeres and their biological consequences.
hematology